BioCryst Pharmaceuticals, Inc. (BCRX)
8.47
-0.05
(-0.59%)
USD |
NASDAQ |
Oct 30, 16:00
8.465
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals 30-Day Average Daily Volume : 5.120M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 5.120M |
| October 29, 2026 | 5.428M |
| October 28, 2026 | 5.451M |
| October 27, 2026 | 5.515M |
| October 26, 2026 | 5.427M |
| October 23, 2026 | 5.451M |
| October 22, 2026 | 5.479M |
| October 21, 2026 | 5.619M |
| October 20, 2026 | 5.623M |
| October 19, 2026 | 5.664M |
| October 16, 2026 | 5.388M |
| October 15, 2026 | 5.306M |
| October 14, 2026 | 5.260M |
| October 13, 2026 | 5.184M |
| October 12, 2026 | 5.175M |
| October 09, 2026 | 5.149M |
| October 08, 2026 | 5.155M |
| October 07, 2026 | 5.046M |
| October 06, 2026 | 4.953M |
| October 05, 2026 | 4.889M |
| October 02, 2026 | 4.815M |
| October 01, 2026 | 4.688M |
| September 30, 2026 | 4.555M |
| September 29, 2026 | 4.190M |
| September 28, 2026 | 4.093M |
| Date | Value |
|---|---|
| September 25, 2026 | 4.076M |
| September 24, 2026 | 4.106M |
| September 23, 2026 | 4.073M |
| September 22, 2026 | 4.092M |
| September 21, 2026 | 4.111M |
| September 18, 2026 | 4.142M |
| September 17, 2026 | 3.852M |
| September 16, 2026 | 3.881M |
| September 15, 2026 | 3.783M |
| September 14, 2026 | 3.686M |
| September 11, 2026 | 3.613M |
| September 10, 2026 | 3.571M |
| September 09, 2026 | 3.344M |
| September 08, 2026 | 3.268M |
| September 04, 2026 | 3.089M |
| September 03, 2026 | 3.101M |
| September 02, 2026 | 3.090M |
| September 01, 2026 | 3.070M |
| August 31, 2026 | 3.034M |
| August 28, 2026 | 3.022M |
| August 27, 2026 | 3.041M |
| August 26, 2026 | 3.077M |
| August 25, 2026 | 3.242M |
| August 24, 2026 | 3.297M |
| August 21, 2026 | 3.335M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Amgen, Inc. | 2.742M |
| Halozyme Therapeutics, Inc. | 2.355M |
| Neurocrine Biosciences, Inc. | 1.318M |
| Agenus, Inc. | 990662.5 |
| Anika Therapeutics, Inc. | 102338.5 |